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Abstract
Background: Vitamin C is a cofactor in the biosynthesis of carnitine, a molecule required for the
oxidation of fatty acids. A reduction in the ability to oxidize fat may contribute to the reported
inverse relationship between vitamin C status and adiposity. To examine this possibility, we
conducted a preliminary trial to evaluate the impact of vitamin C status on fat oxidation during
submaximal exercise.
Methods:  Fat energy expenditure was determined in i n d i v i d u a l s  w i t h  m a r g i n a l  ( n  =  1 5 )  o r
adequate (n = 7) vitamin C status during a submaximal, 60-minute treadmill test. Subsequently,
eight of the subjects with marginal vitamin C status completed an 8-week double-blind, placebo-
controlled, depletion-repletion trial with submaximal exercise testing.
Results: Individuals with marginal vitamin C status oxidized 25% less fat per kg body weight during
the treadmill test as compared to individuals with adequate vitamin C status. Fat oxidation during
exercise was inversely related to fatigue (r = -0.611, p = 0.009). Vitamin C repletion of vitamin C
depleted subjects (500 mg vitamin C/d) raised fat energy expenditure during exercise 4-fold as
compared to depleted control subjects (p = 0.011).
Conclusion: These preliminary results show that low vitamin C status is associated with reduced
fat oxidation during submaximal exercise. Low vitamin C status may partially explain the inverse
relationship between vitamin C status and adiposity and why some individuals are unsuccessful in
their weight loss attempts.
Background
About 15% of US adults are vitamin C deficient (plasma
vitamin C < 11 μmol/L) [1]. Twenty-five years ago, this
percentage was much lower, 3–5% of US adults [2]. Con-
comitant with this recent rise in the prevalence of vitamin
C deficiency, America experienced a major epidemic of
overweight and obesity [3]. Indeed, survey data suggest an
inverse relationship between vitamin C status and body
weight [4,5] and waist measurements [6]. The underlying
systemic oxidative stress associated with obesity has been
proposed to explain the inverse relation between adipos-
ity and plasma vitamin C concentrations [6]. Since vita-
min C is an essential cofactor for the biosynthesis of
carnitine, a molecule required for the oxidation of fatty
acids [7,8], a reduction in the ability to oxidize fat may
contribute to the relationship between vitamin C status
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and adiposity. To examine this possibility, we conducted
a preliminary trial to evaluate the impact of vitamin C
nutriture on fat oxidation during submaximal exercise in
a small sample of young adults.
Methods
Seventy-eight sedentary, non-smoking men and women,
aged 18–38 y, from a campus population were screened
for plasma vitamin C status. Nearly 40% of the sample
had marginal vitamin C status (n = 30; plasma vitamin C
concentration <34 μmol/L), and 15 of these individuals
(mean age, 21.1 ± 0.8 y) agreed to participate in exercise
testing. An additional 7 of the screened individuals with
adequate vitamin C status (plasma vitamin C concentra-
tion ≥ 34 μmol/L) were included as the vitamin C ade-
quate (control) group. All participants provided informed
consent, and the study was conducted in accordance with
the guidelines of the University Institutional Review
Board.
Participants were free of medical conditions contraindi-
cated for exercise testing as set by guidelines of the Amer-
ican College of Sports Medicine. Participants did not
regularly use nutritional supplements and were unaware
of their vitamin C status or the intent of the study. Maxi-
mal oxygen consumption (VO2 max) using a graded walk-
ing protocol was determined. Within 7–10 days of VO2
max testing, participants returned to the laboratory for a
submaximal, 60-minute treadmill walk at 50% of their
VO2 max. Participants were instructed to fast for 4–6 h
prior to the exercise test and to remain sedentary for the
previous 24 h period. Urine samples were collected pre-
and post-exercise to assess urea nitrogen. During the exer-
cise test, oxygen consumption and respiratory exchange
ratio (RER) were measured from three minute gas samples
collected at 10 minute intervals corresponding to minutes
7–10, 17–20, 27–30, etc. Substrate utilization was then
calculated using the non-protein respiratory quotient
derived from the urinary nitrogen and metabolic (VO2
and VCO2) measures. The data reported represent aver-
aged values from samples collected at steady state toward
the end of exercise (i.e., 37, 47, and 57 minutes). Immedi-
ately after testing, participants completed the POMS ques-
tionnaire (Profile of Moods States; EdiTS/Educational and
Industrial Testing Service, San Diego, CA).
Intervention trial
Eight of the 15 participants with marginal vitamin C sta-
tus agreed to participate in an 8-week intervention trial.
These subjects maintained their usual dietary patterns;
however, they were provided with a list of foods to avoid
during the trial. [Although not revealed to the subjects,
these foods contained >30 mg of vitamin C per serving.]
During weeks 1–4, all participants ingested a placebo cap-
sule daily. At the end of this depletion period, subjects
completed a submaximal, 60-minute treadmill walk as
described above. Starting at week 5, the participants were
randomly assigned to receive a placebo capsule (depleted
group; n = 3) or a 500 mg vitamin C capsule (repleted
group; n = 5) daily. A double-blind protocol was fol-
lowed, and the placebo and vitamin C capsules were iden-
tical in appearance. At the end of week 8, participants
completed a 60-minute treadmill walk. Within one week
of the completion of the trial, participants completed a
second VO2 max test utilizing the procedures outlined
above. Fasting blood samples were collected at weeks 5
and 8. An aliquot of plasma was deproteinized in 10%
TCA and frozen at -45°C until analyzed for vitamin C
using 2,4-dinitrophenylhydrazine [9]. Plasma free carni-
tine was measured radiochemically [10], and urinary urea
nitrogen was measured colorimeterically.
Data are reported as mean ± SE, and statistical analyses
were performed using SPSS for WINDOWS (version 12;
SPSS Inc, Chicago). Differences between means were
assessed using an independent t-test, and the Pearson's
correlation was used to identify relationships between
variables. Significance was set at p ≤ 0.05.
Results
Data from the descriptive study showed that RER during
submaximal exercise was significantly higher for individ-
uals with marginal vitamin C status as compared to the
vitamin C adequate controls (p = 0.034; Table 1). Further-
more, fat oxidation during exercise was reduced 25% for
the marginal versus adequate vitamin C groups (p =
0.045). Plasma free carnitine was significantly lower in
the controls as compared to the subjects with marginal
vitamin C status (Table 1). (Although carnitine concentra-
tions in muscle are directly related to vitamin C status,
plasma carnitine concentrations appear to be inversely
related to vitamin C status [11].) Fat oxidation during the
walking test was inversely correlated to fatigue as scored
by the POMS questionnaire (r = -0.611, p = 0.009) and to
plasma carnitine (r = -0.489, p = 0.034). Plasma vitamin
C was inversely related to plasma carnitine (r = -0.794, p
= 0.000), but the correlation between plasma vitamin C
and fat oxidation or RER did not achieve significance (r =
0.309 and r = -0.329 respectively).
Intervention trial
Plasma vitamin C concentrations after the depletion
period (weeks 1–4) averaged 12.3 ± 3.5 μmol/L. Follow-
ing the randomized intervention period (weeks 5–8),
plasma vitamin C concentrations differed significantly
between the repleted and depleted groups (41.7 ± 0.9 and
9.7 ± 1.0 μmol/L respectively, p < 0.001; Figure 1). Fat oxi-
dation was also significantly different by group at week 8
(2.03 ± 0.37 and 0.48 ± 0.11 kcals/kg for the repleted and
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protein oxidation was elevated at week 8 in the depleted
group as compared to the repleted group (0.89 ± 0.28 and
0.37 ± 0.08 kcals/kg respectively, p = 0.062).
When week 4 and week 8 data were combined, plasma
vitamin C concentrations were inversely related to protein
energy expenditure (r = -0.679, p = 0.004) and directly
related to fat energy expenditure (r = 0.655, p = 0.006).
Plasma carnitine was weakly related to plasma vitamin C
(r = -0.441, p = 0.087). A training effect was not evident in
participants since pre- and post-trial VO2 max values were
similar (34.3 ± 3.7 and 36.7 ± 7.9 ml/kg/min versus 32.9
± 4.1 and 34.9 ± 6.7 ml/kg/min for the repleted and
depleted groups respectively at pre-trial versus post-trial).
Discussion
These preliminary data indicate that vitamin C status
impacts fat oxidation. Free-living individuals with mar-
ginal vitamin C status oxidized 25% less fat per kg body
weight during a 60-minute treadmill walk as compared to
individuals with adequate vitamin C status. Moreover, fat
oxidation during exercise was enhanced in these individ-
uals by normalizing plasma vitamin C concentrations.
Vitamin C is a cofactor for two enzymes required for the
biosynthesis of carnitine, ε-N-trimethyl-L-lysine hydroxy-
lase and γ-butyrobetaine hydroxylase [12-15]. Since the
oxidation of fatty acids in skeletal muscle is dependent on
carnitine [7,8], this is a possible mechanism by which
vitamin C affects fat oxidation. We also observed a reduc-
tion in protein oxidation in the vitamin C repleted sub-
jects which is consistent with the protein-sparing effect of
supplemental carnitine [16].
Numerous trials have demonstrated that tissue carnitine
levels are directly related to vitamin C nutriture
[11,17,18], and that plasma vitamin C and carnitine con-
centrations are inversely related [11,19]. However, to our
knowledge, only one other study has examined the rela-
tionship between vitamin C, carnitine metabolism, and
fat oxidation [20]. In cultured hepatocytes, Ha et al. dem-
onstrated that ascorbic acid directly stimulated carnitine
synthesis and the β-oxidation of fatty acids, and reduced
triglyceride accumulation [20]. This observation that vita-
min C reduces fat deposition may explain the reported
inverse relationship between adiposity and vitamin C sta-
tus [4-6]. Interestingly, in patients with an inborn error of
carnitine metabolism, carnitine deficiency is associated
with lipid accumulation in tissues [21-23]. In fact, activa-
tion of the carnitine system has been cited as a possible
treatment for obesity [24-26].
Carnitine deficiency is also associated with fatigue and
exercise intolerance [21-23], and Hughes et al postulated
several decades ago that the lassitude and tiredness of
scurvy may be attributed to carnitine deficiency [17]. Our
data indicated that reduced fat oxidation during exercise
was related to fatigue. It is tempting to speculate that the
reduced fat oxidation associated with vitamin C depletion
may result in weight gain by two mechanisms: indirectly
by fatigability and exercise intolerance and directly by
lipid accumulation. Since 15% of Americans are report-
edly vitamin C deficient, and one-third of Americans have
below adequate vitamin C status [1,27], these issues
deserve further investigation.
Our study had several limitations. The sample sizes were
small, 22 for the descriptive study and eight for the inter-
vention trial, which limits the generalizability of results.
Furthermore, muscle carnitine, the most sensitive marker
of tissue carnitine status, was not assessed in this trial.
Also, since vitamin C is a required cofactor for dopamine
beta-hydroxylase [28], altered norepinephrine responses
in vivo may have impacted fat oxidation in this trial [see
[29]].
Conclusion
These preliminary results show that low vitamin C status
may reduce fat oxidation during submaximal exercise and
that reduced fat oxidation during exercise was related to
fatigue. It is possible that increased fatigue and less reli-
ance on fat as a fuel during activity may influence eventual
weight gain. Thus, in addition to emphasizing calorie con-
Table 1: Baseline characteristics for subjects with marginal (n = 15) or adequate (n = 7) vitamin C status
Marginal vitamin C status Plasma vitamin C <34 μmol/L Adequate vitamin C status Plasma vitamin C ≥34 μmol/
L
p value1
Vitamin C, μmol/L 18.1 ± 2.5 42.9 ± 3.4 .000
BMI, kg/m2 25.0 ± 1.3 23.3 ± 1.4 .436
Total carnitine, ng/ml 12.0 ± 0.8 6.5 ± 0.9 .000
RER2 0.87 ± 0.02 0.83 ± 0.01 .034
Fat energy*, kcals/kg 1.02 ± 0.12 1.36 ± 0.11 .045
VO2max*, ml/kg/min 37.5 ± 2.5 36.9 ± 2.3 .866
1Independent t-test.
2Computed at steady state during 60-minute submaximal walk test.Nutrition & Metabolism 2006, 3:35 http://www.nutritionandmetabolism.com/content/3/1/35
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trol and physical activity, attention to specific diet compo-
nents such as vitamin C may be necessary for effective
weight management.
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RER: respiratory exchange ratio
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Individual subject data for plasma vitamin C concentration 
(A) and for fat energy (B) and protein energy (C) expended 
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and week 8 (post-intervention). Means (± SE) are shown in 
black bars; *p < 0.05; **p = 0.062 (independent t-test)
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